NEW YORK, March 23 (Reuters) - Mylan Laboratories Inc. said on Friday it launched generic versions of Pfizer Inc.'s blockbuster Norvasc blood-pressure drug, a day after a federal court ruled a Pfizer ...

NEW YORK, March 22 (Reuters) - A U.S. appeals court on Thursday reversed a lower court patent decision that had favored Pfizer Inc. in its bid to prevent Canadian drugmaker Apotex Inc. from launching ...

Law360 (December 7, 2006, 12:00 AM EST) -- After a seven-day bench trial, attorneys for Pfizer Inc. and generic drug maker Mylan Pharmaceuticals Inc. made closing arguments Wednesday, putting the ...

The US Food and Drug Administration (FDA) recently issued a safety alert to inform that EpiPen manufacturer, Pfizer, has become aware that the label sticker on certain auto-injectors “may have been ...

New Delhi: Pfizer Ltd on Friday said its board has approved signing a marketing and supply agreement with Mylan ...

PITTSBURGH — Generic drug maker Mylan has settled a patent litigation suit with Pfizer concerning a drug for treating bladder disorders, Mylan said Friday. The Pittsburgh-based company said it settled ...

Pfizer has received final approval for a $50 million settlement to resolve a long-standing multidistrict litigation accusing the pharmaceutical giant of conspiring to inflate the prices of life-saving ...

INDIANAPOLIS — The state of Indiana is suing two of the world's biggest drug companies over the price of EpiPens. Attorney General Todd Rokita claims that Mylan and Pfizer have conspired to increase ...